158 related articles for article (PubMed ID: 37504943)
1. 1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1.
Carbone D; Pecoraro C; Panzeca G; Xu G; Roeten MSF; Cascioferro S; Giovannetti E; Diana P; Parrino B
Mar Drugs; 2023 Jul; 21(7):. PubMed ID: 37504943
[TBL] [Abstract][Full Text] [Related]
2. 1,2,4-Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase.
Carbone D; Parrino B; Cascioferro S; Pecoraro C; Giovannetti E; Di Sarno V; Musella S; Auriemma G; Cirrincione G; Diana P
ChemMedChem; 2021 Feb; 16(3):537-554. PubMed ID: 33141472
[TBL] [Abstract][Full Text] [Related]
3. A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells.
Pecoraro C; Parrino B; Cascioferro S; Puerta A; Avan A; Peters GJ; Diana P; Giovannetti E; Carbone D
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011251
[TBL] [Abstract][Full Text] [Related]
4. Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells.
Cascioferro S; Petri GL; Parrino B; Carbone D; Funel N; Bergonzini C; Mantini G; Dekker H; Geerke D; Peters GJ; Cirrincione G; Giovannetti E; Diana P
Eur J Med Chem; 2020 Mar; 189():112088. PubMed ID: 32007666
[TBL] [Abstract][Full Text] [Related]
5. New 1,2,4-Oxadiazole Nortopsentin Derivatives with Cytotoxic Activity.
Cascioferro S; Attanzio A; Di Sarno V; Musella S; Tesoriere L; Cirrincione G; Diana P; Parrino B
Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30626057
[TBL] [Abstract][Full Text] [Related]
6. Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
Sano M; Ichimaru Y; Kurita M; Hayashi E; Homma T; Saito H; Masuda S; Nemoto N; Hemmi A; Suzuki T; Miyairi S; Hao H
Cancer Lett; 2017 Jul; 397():72-82. PubMed ID: 28347789
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
Akl L; Abd El-Hafeez AA; Ibrahim TM; Salem R; Marzouk HMM; El-Domany RA; Ghosh P; Eldehna WM; Abou-Seri SM
Eur J Med Chem; 2022 Dec; 243():114704. PubMed ID: 36095992
[TBL] [Abstract][Full Text] [Related]
8. 3-(6-Phenylimidazo [2,1-
Cascioferro S; Li Petri G; Parrino B; El Hassouni B; Carbone D; Arizza V; Perricone U; Padova A; Funel N; Peters GJ; Cirrincione G; Giovannetti E; Diana P
Molecules; 2020 Jan; 25(2):. PubMed ID: 31947550
[TBL] [Abstract][Full Text] [Related]
9. Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma.
Carbone D; De Franco M; Pecoraro C; Bassani D; Pavan M; Cascioferro S; Parrino B; Cirrincione G; Dall'Acqua S; Sut S; Moro S; Gandin V; Diana P
Mar Drugs; 2023 May; 21(5):. PubMed ID: 37233482
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
Venkatasubbarao K; Peterson L; Zhao S; Hill P; Cao L; Zhou Q; Nawrocki ST; Freeman JW
Mol Cancer; 2013 Sep; 12(1):104. PubMed ID: 24025152
[TBL] [Abstract][Full Text] [Related]
11. CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
Huang J; Chen P; Liu K; Liu J; Zhou B; Wu R; Peng Q; Liu ZX; Li C; Kroemer G; Lotze M; Zeh H; Kang R; Tang D
Gut; 2021 May; 70(5):890-899. PubMed ID: 32816920
[TBL] [Abstract][Full Text] [Related]
12. The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism.
Zhu H; Xiao Y; Guo H; Guo Y; Huang Y; Shan Y; Bai Y; Lin X; Lu H
Aging (Albany NY); 2021 Dec; 13(23):25089-25105. PubMed ID: 34863080
[TBL] [Abstract][Full Text] [Related]
13. The synthesized 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through the mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells.
Chou LC; Yang JS; Huang LJ; Wu HC; Lu CC; Chiang JH; Chen KT; Kuo SC; Chung JG
J Gastroenterol; 2009; 44(10):1055-63. PubMed ID: 19688288
[TBL] [Abstract][Full Text] [Related]
14. Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma.
Wong MH; Xue A; Baxter RC; Pavlakis N; Smith RC
Neoplasia; 2016 Jul; 18(7):425-35. PubMed ID: 27435925
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
16. Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma.
Aboukameel A; Muqbil I; Senapedis W; Baloglu E; Landesman Y; Shacham S; Kauffman M; Philip PA; Mohammad RM; Azmi AS
Mol Cancer Ther; 2017 Jan; 16(1):76-87. PubMed ID: 28062705
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic Nitrobenzoyl Sesquiterpenoids from an Antarctica Sponge-Derived
Sun C; Liu X; Sun N; Zhang X; Shah M; Zhang G; Che Q; Zhu T; Li J; Li D
J Nat Prod; 2022 Apr; 85(4):987-996. PubMed ID: 35380848
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer.
Avan A; Quint K; Nicolini F; Funel N; Frampton AE; Maftouh M; Pelliccioni S; Schuurhuis GJ; Peters GJ; Giovannetti E
Curr Pharm Des; 2013; 19(5):940-50. PubMed ID: 22973962
[TBL] [Abstract][Full Text] [Related]
19. Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity.
Karelia DN; Kim S; K Pandey M; Plano D; Amin S; Lu J; Sharma AK
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067020
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity.
Chen X; Sun W; Huang S; Zhang H; Lin G; Li H; Qiao J; Li L; Yang S
J Med Chem; 2020 Sep; 63(18):10474-10495. PubMed ID: 32787077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
